Evidence for cancer treatment is constantly evolving. This can result in lag times for system-wide implementation and variability in treatments for Veterans. Clinical Pathways are a decision support tool that bridge this gap by translating published evidence into standardized treatment process maps to help guide treatment decisions.
Clinical Pathways standardize evidence-based practices to ensure high quality, cost-effective care for Veterans at each point in their care plan. Clinical Pathways are different from treatment guidelines, as Clinical Pathways recommend a standard treatment based on efficacy, toxicity, and cost. Guidelines, on the other hand, offer treatment options without always prioritizing specific recommendations. Clinical Pathways are developed by an interdisciplinary subject matter expert group and approved by national program offices including medical oncology, radiation oncology, surgery, pathology, and pharmacy.
Esophageal Cancer Clinical Pathway
Head and Neck Cancer Clinical Pathway
Molecular Testing Provisional Recommendations
Brain and Central Nervous System (CNS) Cancer Clinical Pathways
-
Glioblastoma Clinical Pathway
-
IDH Mutant Astrocytoma Clinical Pathway
-
Meningioma Clinical Pathway
-
Oligodendroglioma Clinical Pathway
-
Vestibular Schwannoma Clinical Pathway
Breast Cancer Clinical Pathways
Gastrointestinal Cancer Clinical Pathways
-
Ampullary Cancer Clinical Pathway
-
Anal Cancer Clinical Pathway
-
Biliary Tract Cancer Clinical Pathway
-
Colon Cancer Clinical Pathway
-
Gastric (Stomach) Cancer Clinical Pathway
-
Gastrointestinal (GI) neuroendocrine tumors (NETs) or gastrointestinal carcinoid tumors
-
Hepatocellular Carcinoma (Liver Cancer) Clinical Pathway
-
Pancreatic Cancer Clinical Pathway
-
Rectal Cancer Clinical Pathway
Genitourinary (Genital and Urinary) Cancer Clinical Pathways
-
Bladder Cancer Clinical Pathway
-
Kidney (Renal) Cancer Clinical Pathway
-
Prostate Cancer Clinical Pathway
Hematologic Malignancies (Blood and Blood-Related Cancer Clinical Pathways)
-
Acute Myeloid Leukemia (AML) Clinical Pathway
-
Acute Promyelocytic Leukemia (APL) Clinical Pathway
-
Chronic Myeloid Leukemia Clinical Pathways
-
Classic Hodgkin Lymphoma (Hodgkin Disease) Clinical Pathways
-
Chronic lymphocytic leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Cancer Clinical Pathway
-
Diffuse Large B-Cell Lymphoma Clinical Pathway
-
Essential Thrombocytosis Clinical Pathway
-
Follicular Lymphoma Clinical Pathway
-
Hairy Cell Leukemia Cancer Clinical Pathway
-
Mantle Cell Lymphoma Clinical Pathway
-
Marginal Zone Lymphoma Clinical Pathway
-
Myelodysplastic Syndromes (MDS, or preleukemia) Clinical Pathway
-
Primary Mediastinal B-Cell Lymphoma (PMBCL) Clinical Pathways
-
Primary and Secondary Myelofibrosis Clinical Pathways
-
Plasma Cell Disorders Cancer Clinical Pathway
-
Polycythemia Vera Clinical Pathway
-
Peripheral T-Cell Lymphoma (PTCL) Clinical Pathway
-
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Mesothelioma Clinical Pathway
Salivary Gland Cancer Clinical Pathway